Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02612389 · ClinicalTrials.gov registry record · NA

Meditative Movement for COPD Symptoms in Non-Smoking Flight Attendants

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
220
Enrollment target

NCT02612389 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 220 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02612389, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
220 participants
Enrollment target

Study Summary

This study will explore the a Qigong based exercise intervention, here referred to as Meditative Movement (MM), to ameliorate the symptoms associated with chronic obstructive pulmonary disease (COPD) and its co-morbidities. It tests the hypothesis that MM will have a beneficial effect on COPD in FA, particularly on functional ability, respiratory symptoms, affective state, inflammation, and autonomic imbalance. If the hypothesis is correct, MM could be rapidly and inexpensively taught to FA with COPD and other COPD patients to slow degeneration and improve quality of life.

Interventions

  • OTHER Meditative Movement taught via DVD

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2015-03
Est. Completion 2020-07-17
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT02612389

The ClinicalTrials.gov registry entry for NCT02612389 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Meditative Movement taught via DVD is the first listed.

NCT02612389 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02612389 about?

NCT02612389 is a clinical study titled "Meditative Movement for COPD Symptoms in Non-Smoking Flight Attendants". This study will explore the a Qigong based exercise intervention, here referred to as Meditative Movement (MM), to ameliorate the symptoms associated with chronic obstructive pulmonary disease (COPD) and its co-morbidities. It tests the hypothesis that MM will have a beneficial effect on COPD in FA,...

What is the current status of trial NCT02612389?

This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2015-03. Estimated completion is 2020-07-17.

What interventions are being tested in trial NCT02612389?

The interventions under investigation include: Meditative Movement taught via DVD (OTHER).

Who is sponsoring clinical trial NCT02612389?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.